vs
Natera, Inc.（NTRA）与RadNet, Inc.（RDNT）财务数据对比。点击上方公司名可切换其他公司
Natera, Inc.的季度营收约是RadNet, Inc.的1.2倍（$665.5M vs $547.7M）。Natera, Inc.净利率更高（7.1% vs -0.1%，领先7.2%）。Natera, Inc.同比增速更快（39.8% vs 14.8%）。过去两年Natera, Inc.的营收复合增速更高（34.5% vs 12.6%）
Natera是总部位于美国得克萨斯州奥斯汀的临床基因检测企业，主打无创游离DNA（cfDNA）检测技术，业务覆盖女性健康、肿瘤及器官健康三大核心赛道。其自研专利技术结合前沿分子生物学手段与生物信息学工具矩阵，可实现单管血液样本中低至单个分子级别的高灵敏度检测。
RadNet是美国领先的放射医疗服务企业，总部位于加利福尼亚州洛杉矶，是美国规模最大的独立固定地址诊断影像中心运营商，按网点数量及年度影像业务收入计均居行业首位。截至2025年，该公司在全美8个州持有或运营超400家影像中心，提供门诊诊断影像服务。
NTRA vs RDNT — 直观对比
营收规模更大
NTRA
是对方的1.2倍
$547.7M
营收增速更快
NTRA
高出25.0%
14.8%
净利率更高
NTRA
高出7.2%
-0.1%
两年增速更快
NTRA
近两年复合增速
12.6%
损益表 — Q4 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $665.5M | $547.7M |
| 净利润 | $47.3M | $-597.0K |
| 毛利率 | — | — |
| 营业利润率 | -3.4% | 5.1% |
| 净利率 | 7.1% | -0.1% |
| 营收同比 | 39.8% | 14.8% |
| 净利润同比 | 187.9% | -111.2% |
| 每股收益（稀释后） | $0.36 | $0.00 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收NTRARDNT
| Q4 25 | $665.5M | $547.7M | ||
| Q3 25 | $592.2M | $522.9M | ||
| Q2 25 | $546.6M | $498.2M | ||
| Q1 25 | $501.8M | $471.4M | ||
| Q4 24 | $476.1M | $477.1M | ||
| Q3 24 | $439.8M | $461.1M | ||
| Q2 24 | $413.4M | $459.7M | ||
| Q1 24 | $367.7M | $431.7M |
净利润NTRARDNT
| Q4 25 | $47.3M | $-597.0K | ||
| Q3 25 | $-87.5M | $5.4M | ||
| Q2 25 | $-100.9M | $14.5M | ||
| Q1 25 | $-66.9M | $-37.9M | ||
| Q4 24 | $-53.8M | $5.3M | ||
| Q3 24 | $-31.6M | $3.2M | ||
| Q2 24 | $-37.5M | $-3.0M | ||
| Q1 24 | $-67.6M | $-2.8M |
营业利润率NTRARDNT
| Q4 25 | -3.4% | 5.1% | ||
| Q3 25 | -16.5% | 5.2% | ||
| Q2 25 | -20.2% | 6.2% | ||
| Q1 25 | -15.8% | -5.1% | ||
| Q4 24 | -13.6% | 5.1% | ||
| Q3 24 | -8.9% | 7.4% | ||
| Q2 24 | -10.6% | 7.6% | ||
| Q1 24 | -20.2% | 2.6% |
净利率NTRARDNT
| Q4 25 | 7.1% | -0.1% | ||
| Q3 25 | -14.8% | 1.0% | ||
| Q2 25 | -18.5% | 2.9% | ||
| Q1 25 | -13.3% | -8.0% | ||
| Q4 24 | -11.3% | 1.1% | ||
| Q3 24 | -7.2% | 0.7% | ||
| Q2 24 | -9.1% | -0.6% | ||
| Q1 24 | -18.4% | -0.6% |
每股收益（稀释后）NTRARDNT
| Q4 25 | $0.36 | $0.00 | ||
| Q3 25 | $-0.64 | $0.07 | ||
| Q2 25 | $-0.74 | $0.19 | ||
| Q1 25 | $-0.50 | $-0.51 | ||
| Q4 24 | $-0.41 | $0.08 | ||
| Q3 24 | $-0.26 | $0.04 | ||
| Q2 24 | $-0.30 | $-0.04 | ||
| Q1 24 | $-0.56 | $-0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $767.2M |
| 总债务越低越好 | — | $1.1B |
| 股东权益账面价值 | $1.7B | $1.1B |
| 总资产 | $2.4B | $3.8B |
| 负债/权益比越低杠杆越低 | — | 1.00× |
8季度趋势，按日历期对齐
现金及短期投资NTRARDNT
| Q4 25 | — | $767.2M | ||
| Q3 25 | $1.0M | $804.7M | ||
| Q2 25 | $16.0M | $833.2M | ||
| Q1 25 | $17.8M | $717.3M | ||
| Q4 24 | $22.7M | $740.0M | ||
| Q3 24 | $29.5M | $748.9M | ||
| Q2 24 | $90.3M | $741.7M | ||
| Q1 24 | $69.1M | $527.0M |
总债务NTRARDNT
| Q4 25 | — | $1.1B | ||
| Q3 25 | — | $1.1B | ||
| Q2 25 | — | $1.1B | ||
| Q1 25 | — | $1.0B | ||
| Q4 24 | — | $1.0B | ||
| Q3 24 | — | $1.0B | ||
| Q2 24 | — | $1.0B | ||
| Q1 24 | — | $834.6M |
股东权益NTRARDNT
| Q4 25 | $1.7B | $1.1B | ||
| Q3 25 | $1.3B | $1.1B | ||
| Q2 25 | $1.2B | $932.3M | ||
| Q1 25 | $1.2B | $898.1M | ||
| Q4 24 | $1.2B | $902.3M | ||
| Q3 24 | $878.5M | $895.3M | ||
| Q2 24 | $836.5M | $881.0M | ||
| Q1 24 | $794.1M | $873.0M |
总资产NTRARDNT
| Q4 25 | $2.4B | $3.8B | ||
| Q3 25 | $1.8B | $3.7B | ||
| Q2 25 | $1.8B | $3.5B | ||
| Q1 25 | $1.7B | $3.3B | ||
| Q4 24 | $1.7B | $3.3B | ||
| Q3 24 | $1.6B | $3.3B | ||
| Q2 24 | $1.5B | $3.2B | ||
| Q1 24 | $1.5B | $3.0B |
负债/权益比NTRARDNT
| Q4 25 | — | 1.00× | ||
| Q3 25 | — | 1.04× | ||
| Q2 25 | — | 1.18× | ||
| Q1 25 | — | 1.12× | ||
| Q4 24 | — | 1.13× | ||
| Q3 24 | — | 1.14× | ||
| Q2 24 | — | 1.17× | ||
| Q1 24 | — | 0.96× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $73.9M | $84.2M |
| 自由现金流经营现金流 - 资本支出 | $37.8M | — |
| 自由现金流率自由现金流/营收 | 5.7% | — |
| 资本支出强度资本支出/营收 | 5.4% | — |
| 现金转化率经营现金流/净利润 | 1.56× | — |
| 过去12个月自由现金流最近4个季度 | $109.1M | — |
8季度趋势，按日历期对齐
经营现金流NTRARDNT
| Q4 25 | $73.9M | $84.2M | ||
| Q3 25 | $59.4M | $52.8M | ||
| Q2 25 | $37.6M | $120.3M | ||
| Q1 25 | $44.5M | $41.5M | ||
| Q4 24 | $52.9M | $42.5M | ||
| Q3 24 | $51.8M | $57.4M | ||
| Q2 24 | $4.0M | $116.0M | ||
| Q1 24 | $27.0M | $17.1M |
自由现金流NTRARDNT
| Q4 25 | $37.8M | — | ||
| Q3 25 | $37.0M | — | ||
| Q2 25 | $11.7M | — | ||
| Q1 25 | $22.6M | — | ||
| Q4 24 | $34.8M | — | ||
| Q3 24 | $35.5M | — | ||
| Q2 24 | $-7.7M | — | ||
| Q1 24 | $6.7M | — |
自由现金流率NTRARDNT
| Q4 25 | 5.7% | — | ||
| Q3 25 | 6.2% | — | ||
| Q2 25 | 2.1% | — | ||
| Q1 25 | 4.5% | — | ||
| Q4 24 | 7.3% | — | ||
| Q3 24 | 8.1% | — | ||
| Q2 24 | -1.9% | — | ||
| Q1 24 | 1.8% | — |
资本支出强度NTRARDNT
| Q4 25 | 5.4% | — | ||
| Q3 25 | 3.8% | — | ||
| Q2 25 | 4.7% | — | ||
| Q1 25 | 4.3% | — | ||
| Q4 24 | 3.8% | — | ||
| Q3 24 | 3.7% | — | ||
| Q2 24 | 2.8% | — | ||
| Q1 24 | 5.5% | — |
现金转化率NTRARDNT
| Q4 25 | 1.56× | — | ||
| Q3 25 | — | 9.75× | ||
| Q2 25 | — | 8.33× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 7.96× | ||
| Q3 24 | — | 17.89× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
NTRA
暂无分部数据
RDNT
| Commercial Insurance1 | $301.0M | 55% |
| Medicare1 | $129.2M | 24% |
| Capitation Arrangements | $31.9M | 6% |
| Health Care Other | $20.4M | 4% |
| Digital Health | $16.4M | 3% |
| Other | $15.2M | 3% |
| Medicaid1 | $14.0M | 3% |
| Workers Compensation Personal Injury1 | $12.3M | 2% |
| Health Care Management Service | $7.5M | 1% |
